Join Growin Stock Community!
Beta
Back to CVS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
eps-chart

CVS EPS

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for CVS's EPS in Q1'26 stands at 2.31 USD, reflecting a solid recovery from the previous quarter's negative performance and marking one of the highest values in the observed period. Over the timeframe from Q2'23 to Q1'26, CVS's EPS exhibits high volatility with an overall upward trend, starting at 1.48 USD and fluctuating through lows of -3.13 USD in Q3'25 before rebounding to 2.33 USD in Q4'25 and stabilizing near 2.31 USD; notable declines include a sharp drop to 0.07 USD in Q3'24 and the Q3'25 plunge, while year-over-year growth shows extreme swings, such as a -45.7% contraction in Q3'25 contrasted by a 167.7% surge in Q3'23, indicating inconsistent profitability amid operational challenges. The bar chart visualization highlights these quarterly inconsistencies, with the overlaid line for EPS growth underscoring periods of contraction (e.g., -96.0% in Q3'24) and recovery (e.g., 77.9% in Q4'25).